Find News

Filter articles

Applied Filters

Showing 61 to 70 of 706 results

Sequenom and Illumina prevail in UK confidentiality dispute


The England and Wales High Court has ruled in favour of Sequenom and Illumina, after the companies asked the court to rule that they were entitled to receive confidential information in legal proceedings against three competitors without additional restriction.

EPO invalidates Pacific Biosciences patent in Oxford Nanopore dispute

EPO, EU23-01-2019

The European Patent Office has revoked a patent held by a US biotechnology company, Pacific Biosciences, after its UK-based rival Oxford Nanopore Technologies challenged the validity of the patent.

South Korean global licensing spikes n 2018

South Korea22-01-2019

South Korean pharmaceutical companies entered into 11 out-licensing deals with overseas partners in 2018, according to the country’s Ministry of Health and Welfare.

GE Healthcare partners with Vanderbilt University to create AI apps


US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.

FDA announces new measures to boost gene therapy innovation


The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.

McGuire Woods adds three partners to life sciences team


US law firm McGuire Woods is expanding its life sciences patent litigation team with the addition of three partners in its New York office.

Sanofi collaborates with Biomunex to develop antibody therapeutics


Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.

Surge in life sciences investment in Catalonia: report

EU, Spain10-01-2019

The number of international investors in life sciences start-ups in the Catalonia region in Spain has multiplied by ten in the last five years, according to a new report.

US Supreme Court refuses to hear appeal against ‘unclean hands’ decision


The US Supreme Court has refused to hear an appeal against a ruling that American pharmaceutical firm Merck & Co cannot collect $200 million in damages due to its misconduct during a trial.

Locus licenses CRISPR tech to Janssen in potential $818m deal

Belgium, US09-01-2019

US-based Locus Biosciences has announced it will license its CRISPR-Cas3 technology to Janssen, a subsidiary of American pharmaceutical company Johnson & Johnson, in a deal worth a potential $818 million.

Showing 61 to 70 of 706 results